What is the maximum dose of famotidine (H2 receptor antagonist) per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Famotidine

The maximum recommended dose of famotidine is 40 mg daily for most standard indications, though doses up to 160 mg every 6 hours (640 mg/day) may be used for pathological hypersecretory conditions. 1

Standard Maximum Dosing by Indication

The FDA-approved maximum doses vary significantly based on the clinical indication 1:

  • Active duodenal or gastric ulcer: 40 mg once daily (or 20 mg twice daily) 1
  • GERD (non-erosive): 20 mg twice daily (total 40 mg/day) 1
  • Erosive esophagitis: 20-40 mg twice daily (total 40-80 mg/day) 1
  • Stress ulcer prophylaxis in ICU: 40 mg daily 2
  • Pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome): Starting dose 20 mg every 6 hours, with maximum dose of 160 mg every 6 hours (640 mg/day total) 1

Special Clinical Contexts

Critical Care and Premedication

  • Premedication protocols: 20 mg IV or PO is the standard dose 3
  • Perioperative use: 20 mg IM provides acid suppression for approximately 6 hours when oral/IV routes are unavailable 3

Pediatric Dosing

  • Children weighing ≥40 kg: Use adult dosing as above 1
  • Children <40 kg: Maximum 1 mg/kg/day divided in 2 doses 2
  • The 20 mg and 40 mg tablet formulations should not be used in children <40 kg; use alternative formulations 1

Renal Impairment Adjustments

Dosage reduction is mandatory for moderate to severe renal impairment 1:

  • Creatinine clearance 30-60 mL/min: Maximum 20 mg once daily or 40 mg every other day 1
  • Creatinine clearance <30 mL/min: Maximum 20 mg every other day 1
  • Pathological hypersecretory conditions with renal impairment: Avoid use due to unknown risk profile at high doses 1

Important Clinical Caveats

Duration of Action and Dosing Frequency

  • Oral famotidine provides antisecretory activity for 10-12 hours, supporting twice-daily dosing for sustained acid suppression 3
  • IM famotidine provides approximately 6 hours of acid suppression 3

Tachyphylaxis

  • Tolerance develops within 6 weeks of continuous H2-receptor antagonist therapy, requiring periodic reassessment 3

Drug Interactions

  • Famotidine does not interfere with clopidogrel antiplatelet activity, making it preferred over PPIs in patients on dual antiplatelet therapy 4, 3, 5
  • Unlike cimetidine, famotidine does not alter hepatic drug metabolism via cytochrome P-450 6, 7

High-Dose Tolerance

  • Patients with Zollinger-Ellison syndrome have tolerated doses up to 800 mg daily in clinical experience, though the FDA maximum is 640 mg/day 7
  • The excellent tolerability profile observed in trials has remained unchanged in postmarketing surveillance 7

Comparative Efficacy by Dose

  • For erosive esophagitis, 40 mg twice daily (80 mg/day total) is significantly more effective than 20 mg twice daily, particularly for severe grades (III-IV) 8
  • Healing rates at 12 weeks: 76% with 40 mg twice daily versus 67% with 20 mg twice daily 8

References

Guideline

Maximum Recommended Dose of Famotidine for Specific Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Famotidine Administration and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Famotidine Dosing and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The tolerability and safety profile of famotidine.

Clinical therapeutics, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.